Advertisement

Latest Articles in Regulatory

Biocon Biologics Secures US Entry Date For Bmab 1200, A Stelara Biosimilar

Under the agreement, Biocon Biologics is licensed to launch Bmab 1200 in the United States, scheduled for February 2025, subject to approval by the U.S. FDA

Read More

No Development Without Research

For India and Indian companies to fulfil their enormous promise, a greater outlay towards research is paramount

Read More

Interim Budget Generates Serious Questions From India's FinMin

The shortest budget, very high on rhetoric, throws up serious questions which the discerning public demands answers, writes JK Dadoo

Read More

Innovative Optical Technology Receives Second Patent Boost In India

This additional patent solidifies and augments the original invention, unveiling unique features with the potential to enhance precision and productivity across various applications

Read More

Zydus Lifesciences Receives USFDA Nod For Generic Gabapentin Tablets

The company received final approval for manufacturing and marketing Gabapentin tablets in 300 mg and 600 mg strengths, making it the first to receive such approval

Read More

Alembic Pharmaceuticals Gets USFDA Approvals For Eight Drug Applications

The approvals include five final approvals for medications such as Selexipag Tablets (multiple strengths), Dapsone gel (7.5 per cent), Fluorouracil Injection USP 5g/100mL (50 mg/mL), Carmustine for Injection USP 100 mg/vial, and Acyclovir Cream (5 per cent)

Read More

Lupin Receives FDA Approval For Generic Equivalent Of Alrex Ophthalmic Suspension

This approval positions Lupin to market a generic equivalent to the reference listed drug (RLD) Alrex Ophthalmic Suspension, 0.2 per cent, produced by Bausch & Lomb

Read More

FDA Requests Additional Study For Amgen's Lumakras

Lumakras, an oral drug, is specifically designed to target a mutated form of the KRAS gene, occurring in approximately 13 per cent of non-small cell lung cancers, the most prevalent form of lung cancer, and less frequently in some other solid tumours

Read More

FDA Seizes Counterfeit Ozempic: Thousands Of Fake Diabetes Drug Units Circulate, Health Warning Issued

Reportedly, Novo Nordisk, the manufacturer of Ozempic, is collaborating with the FDA to conduct testing on the seized counterfeit shots

Read More

AstraZeneca India Receives Approval For Triple Combination Inhaler For COPD Treatment

In comparison to currently available dual therapies, this triple combination therapy is proven to considerably lower the rate of moderate to severe exacerbations, and mortality rates, and increase lung function

Read More